Researchers have developed a system that may help predict which candidates for surgery are likely to achieve type 2 diabetes remission.
A large international dataset analyzing type 1 diabetics in 12 countries has found that men may be better at blood sugar control than women.
A new approachhas produced substantially improved results for patients with type 1 diabetes and may offer a more durable alternative.
Not all experts are happy with granting wider access to the troubled medication, however.
Diabetes control and medication adherence improve; fewer trips to the emergency room.
ACE inhibitor plus ARB failed to slow disease progression but increased acute kidney injury risk.
Guidelines recommend universal testing for diabetes early in pregnancy, evidence-based care.
For the conventional benchmark of $50,000 per QALY, a threshold of 105 mg/dL for type 2 diabetes mellitus is cost-effective.
Increasing age and receipt of a deceased-donor kidney were among risk factors for death from infection.
Atorvastatin did not reduce the risk of a combined endpoint of cardiovascular death, MI, and stroke.
Researchers speculate patients on peritoneal dialysis are more physically active than those on HD, and this may lower diabetes risk.
High A1c values are associated with a twofold increased likelihood of cardiovascular death or non-fatal cardiovascular events.
New findings are based on a study of 472 patients with stage 4-5 chronic kidney disease.
Women with diabetes have a higher prevalence of risk factors for chronic kidney disease than men.
The proportion of patients with prediabetes was 14.7% for patients aged 45-55 years versus 20.8% for those aged 65-75.
A cFLC level greater than 57.2 mg/L was independently associated with a 3.3 times increased risk for adverse CVD outcomes.
Low and high serum ferritin, high serum soluble transferrin receptor levels predict poor prognosis.
New treatments that restore and increase mitochondrial function and content could ameliorate or even arrest CKD, according to investigators.